Skip to content

Hong Kong-based company Home Control 1747 HK establishes a health subsidiary aimed at improving health services in Hong Kong by 2025.

Medical entity intrudes on telehealth and Internet of Things (IoT) medical devices, providing Hong Kong healthcare stock terms and pipeline details to investors.

Hong Kong-based Home Control 1747 HK Establishes Health Subsidiary by the Year 2025 for the HK...
Hong Kong-based Home Control 1747 HK Establishes Health Subsidiary by the Year 2025 for the HK Health Sector

Hong Kong-based company Home Control 1747 HK establishes a health subsidiary aimed at improving health services in Hong Kong by 2025.

Home Control Pivots into Healthcare, Unveiling Global Health Services Ecosystem

Home Control (1747.HK), a company with roots traced back to Philips Group's former home control division in the Netherlands, has announced a significant strategic pivot. The company, known for its smart home solutions and IoT connectivity, is now stepping into the healthcare sector with the establishment of a wholly owned subsidiary in Hong Kong.

The new subsidiary, set to serve as an incubator for smart health hardware, aims to develop a full-fledged ecosystem for health monitoring and management. This move represents a logical extension of Home Control's capabilities in data interoperability, aligning with its vision to bridge the data gap between households and clinics.

The market is closely watching Home Control's execution of this vision, as the company aims to integrate resources and connect stakeholders across the value chain. This people-centric platform, which integrates medical resources with service innovation, is expected to revolutionise the global health services landscape.

Singapore's Ministry of Health announced in late 2024 that private hospitals would integrate with the national electronic health records system, paving the way for such transformative initiatives. The subsidiary's location in Hong Kong suggests Asia will be the initial focus, with global expansion to follow.

Investors view healthcare as a transformative growth driver for Home Control. With the global healthcare IT market expected to expand from USD 587.9 billion in 2025 to USD 1.225 trillion by 2029, the company's valuation is anticipated to see a meaningful re-rating as it captures share in this trillion-dollar "blue ocean" market.

China's "Healthy China 2030" blueprint targets a RMB 16 trillion healthcare services market by 2030, offering a promising landscape for Home Control's expansion. The company is experimenting with innovative models of healthcare delivery, positioning itself well for long-term structural growth.

However, details about the persons leading the newly founded Home Control subsidiary in Hong Kong responsible for expansion in home healthcare are yet to be disclosed.

In the first half of 2025, Home Control's healthcare solutions became the second-largest revenue contributor, accounting for approximately 20% of total sales. Beyond hardware, Home Control is building proprietary in-home healthcare solutions, setting the stage for an exciting future in the healthcare sector.

As Home Control embarks on this new journey, the company's strategic vision remains clear: to build a global health services ecosystem that will redefine the future of healthcare. The market eagerly awaits the execution of this vision, as Home Control sets out to transform the healthcare landscape on a global scale.

Read also:

Latest